Other Species / Isoforms
  NR2C2 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T13-p
PRIQIIStDSAVAsP
0 1
NR2C2 (human) PRIQIISTDsAVAsP T13
NR2C2 iso2 (human) PRIQIISTDSAVAsP T13
NR2C2 (mouse) PRIQIIStDSAVAsP T13-p
NR2C2 (rat) PRIQIISTDSAVRSP T13
S15
IQIIStDSAVAsPQR
0 1
NR2C2 (human) IQIISTDsAVAsPQR S15-p
NR2C2 iso2 (human) IQIISTDSAVAsPQR S15
NR2C2 (mouse) IQIIStDSAVAsPQR S15
NR2C2 (rat) IQIISTDSAVRSPQR S15
S19-p
StDSAVAsPQRIQIV
Downstream
1 21
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, altered
NR2C2 (human) STDsAVAsPQRIQIV S19-p
NR2C2 iso2 (human) STDSAVAsPQRIQGS S19-p
NR2C2 (mouse) StDSAVAsPQRIQIV S19-p
NR2C2 (rat) STDSAVRSPQRIQIV S19
S46
TAVDASGSSKQQFIL
0 14
NR2C2 (human) TAVDASGsPKQQFIL S46-p
NR2C2 iso2 (human) TAVDASGSPKQQFIL S65
NR2C2 (mouse) TAVDASGSSKQQFIL S46
NR2C2 (rat) TAVDASGSSKQQFIL S46
S55-p
KQQFILTsPDGAGTG
1 7
NR2C2 (human) KQQFILTsPDGAGTG S55-p
NR2C2 iso2 (human) KQQFILTSPDGAGTG S74
NR2C2 (mouse) KQQFILTsPDGAGTG S55-p
NR2C2 (rat) KQQFILTSPDGAGTG S55
K63
PDGAGTGKVILAsPE
0 1
NR2C2 (human) PDGAGTGkVILAsPE K63-ub
NR2C2 iso2 (human) PDGAGTGKVILASPE K82
NR2C2 (mouse) PDGAGTGKVILAsPE K63
NR2C2 (rat) PDGAGTGKVILASPE K63
S68-p
TGKVILAsPETSSAK
Upstream
Downstream
1 14
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, altered
Regulatory protein:
  • MPRIP (mouse)
NR2C2 (human) TGkVILAsPETSSAK S68-p
NR2C2 iso2 (human) TGKVILASPETSSAK S87
NR2C2 (mouse) TGKVILAsPETSSAK S68-p
NR2C2 (rat) TGKVILASPETSSAK S68
S98
QIVTDSASVERLLGK
0 3
NR2C2 (human) QIVTDSAsVERLLGK S98-p
NR2C2 iso2 (human) QIVTDSASVERLLGK S117
NR2C2 (mouse) QIVTDSASVERLLGK S98
NR2C2 (rat) QIVTDSASVERLLGK S98
Y116
QRPQVVEYCVVCGDK
0 1
NR2C2 (human) QRPQVVEyCVVCGDK Y116-p
NR2C2 iso2 (human) QRPQVVEYCVVCGDK Y135
NR2C2 (mouse) QRPQVVEYCVVCGDK Y116
NR2C2 (rat) QRPQVVEYCVVCGDK Y116
K192
ESVQSERKPFDVQRE
0 1
NR2C2 (human) ESVQSERkPFDVQRE K192-ub
NR2C2 iso2 (human) ESVQSERKPFDVQRE K211
NR2C2 (mouse) ESVQSERKPFDVQRE K192
NR2C2 (rat) ESVQSERKPFDVQRE K192
S219-p
YIRKDLRsPLIAtPT
Upstream
0 47
Treatment
  • insulin
  • LPS
NR2C2 (human) YIRKDLRsPLIAtPt S219-p
NR2C2 iso2 (human) YIRKDLRSPLIATPT S238
NR2C2 (mouse) YIRKDLRsPLIAtPT S219-p
NR2C2 (rat) YIRKDLRsPLIATPT S219-p
T224-p
LRsPLIAtPTFVADK
0 35
NR2C2 (human) LRsPLIAtPtFVADk T224-p
NR2C2 iso2 (human) LRSPLIATPTFVADK T243
NR2C2 (mouse) LRsPLIAtPTFVADK T224-p
NR2C2 (rat) LRsPLIATPTFVADk T224
T226
sPLIAtPTFVADKDG
0 10
NR2C2 (human) sPLIAtPtFVADkDG T226-p
NR2C2 iso2 (human) SPLIATPTFVADKDG T245
NR2C2 (mouse) sPLIAtPTFVADKDG T226
NR2C2 (rat) sPLIATPTFVADkDG T226
K231
tPTFVADKDGARQTG
0 3
NR2C2 (human) tPtFVADkDGARQTG K231-ac
NR2C2 iso2 (human) TPTFVADKDGARQTG K250
NR2C2 (mouse) tPTFVADKDGARQTG K231
NR2C2 (rat) TPTFVADkDGSRQTG K231-ac
K231
tPTFVADKDGARQTG
0 2
NR2C2 (human) tPtFVADkDGARQTG K231-ub
NR2C2 iso2 (human) TPTFVADKDGARQTG K250
NR2C2 (mouse) tPTFVADKDGARQTG K231
NR2C2 (rat) TPTFVADKDGSRQTG K231
T322
TLAKALNTtDSAsPP
0 1
NR2C2 (human) TLAKALNtTDSSSsP T322-p
NR2C2 iso2 (human) TLAKALNTTDSSSSP T341
NR2C2 (mouse) TLAKALNTtDSAsPP T322
NR2C2 (rat) TLAKALNTTDSASPP T322
T323-p
LAKALNTtDSAsPPS
0 1
NR2C2 (human) LAKALNtTDSSSsPs T323
NR2C2 iso2 (human) LAKALNTTDSSSSPS T342
NR2C2 (mouse) LAKALNTtDSAsPPS T323-p
NR2C2 (rat) LAKALNTTDSASPPS T323
S327-p
LNTtDSAsPPSLADG
0 1
NR2C2 (human) LNtTDSSSsPsLADG S327
NR2C2 iso2 (human) LNTTDSSSSPSLADG S346
NR2C2 (mouse) LNTtDSAsPPSLADG S327-p
NR2C2 (rat) LNTTDSASPPSLADG S327
P328
NTtDSAsPPSLADGI
0 2
NR2C2 (human) NtTDSSSsPsLADGI S328-p
NR2C2 iso2 (human) NTTDSSSSPSLADGI S347
NR2C2 (mouse) NTtDSAsPPSLADGI P328
NR2C2 (rat) NTTDSASPPSLADGI P328
S330
tDSAsPPSLADGIDA
0 1
NR2C2 (human) TDSSSsPsLADGIDT S330-p
NR2C2 iso2 (human) TDSSSSPSLADGIDT S349
NR2C2 (mouse) tDSAsPPSLADGIDA S330
NR2C2 (rat) TDSASPPSLADGIDA S330
S351-p
HVISRDQstPIIEVE
Upstream
Downstream
1 3
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • signaling pathway regulation
  • transcription, inhibited
Kinase, in vitro:
  • AMPKA1 (human)
Putative in vivo kinases:
  • AMPKA1 (human)
Treatment
  • acadesine
  • metformin
  • siRNA
NR2C2 (human) HVISRDQstPIIEVE S351-p
NR2C2 iso2 (human) HVISRDQSTPIIEVE S370
NR2C2 (mouse) HVISRDQstPIIEVE S351-p
NR2C2 (rat) HVISRDQStPIIEVE S351
T352-p
VISRDQstPIIEVEG
0 76
NR2C2 (human) VISRDQstPIIEVEG T352-p
NR2C2 iso2 (human) VISRDQSTPIIEVEG T371
NR2C2 (mouse) VISRDQstPIIEVEG T352-p
NR2C2 (rat) VISRDQStPIIEVEG T352-p
S363
EVEGPLLSDTHVTFK
0 1
NR2C2 (human) EVEGPLLsDTHVTFK S363-p
NR2C2 iso2 (human) EVEGPLLSDTHVTFK S382
NR2C2 (mouse) EVEGPLLSDTHVTFK S363
NR2C2 (rat) EVEGPLLSDTHVTFK S363
K516
TGTSQIEKFQEKAQM
0 1
NR2C2 (human) TSTSQIEkFQEKAQM K516-ub
NR2C2 iso2 (human) TSTSQIEKFQEKAQM K535
NR2C2 (mouse) TGTSQIEKFQEKAQM K516
NR2C2 (rat) TGTSQIEKFQEKAQM K516
K531
ELQDYVQKTYSEDTY
0 1
NR2C2 (human) ELQDYVQkTYSEDTY K531-ub
NR2C2 iso2 (human) ELQDYVQKTYSEDTY K550
NR2C2 (mouse) ELQDYVQKTYSEDTY K531
NR2C2 (rat) ELQDYVQKTYSEDTY K531
S571
TGLIGNVSIDSIIPY
0 1
NR2C2 (human) TGLIGNVsIDSIIPY S571-p
NR2C2 iso2 (human) TGLIGNVSIDSIIPY S590
NR2C2 (mouse) TGLIGNVSIDSIIPY S571
NR2C2 (rat) TGLIGNVSIDSIIPY S571